Abstract
Concern over the development of tolerance in patients on continuous intrathecal baclofen therapy has arisen as this new form of treatment for spasticity has gained wider use. We have studied time-dose relationships in 18 spinal cord injured patients who have undergone intrathecal baclofen infusion pump implantation since February 1988 in our facility. Our data show that there was a significant increase in baclofen dosage needed to control spasticity during the first 12 months post implantation. After 12 months, however, no significant change in dosage requirement was detected. In addition, there was no significant difference between completely and incompletely spinal cord injured patients with regard to both the initial dose and the tolerance trend.
Similar content being viewed by others
Article PDF
References
Penn R D, Kroin J S (1987) Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 66(2): 181–5.
Muller H, Zierski J, Dralle D, Borner U, Hoffmann O (1987) The effect of intrathecal baclofen on electrical muscle activity in spasticity. J Neurol 234(5): 348–52.
Zierski J, Muller H, Dralle D, Wurdinger T (1988) Implanted pump systems for treatment of spasticity. Acta Neurochir Suppl (Wien) 43: 94–9.
Parke B, Penn R D, Savoy S M, Carcos D (1989) Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehabil 70(1): 30–2.
Penn R D, Savoy S M, Corcos D, Latash M, Gottlieb G, Parke B et al (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320(23): 1517–21.
Ochs G, Struppler A, Meyerson B A, Linderoth B, Gybels J, Gardner B P, Teddy P et al (1989) Intrathecal baclofen for long-term treatment of spasticity: a multi-center study. J Neurol Neurosurg Psychiatry 52: 933–9.
Broseta J, Garcia-March G, Sanchez-Ledesma M J, Anaya J, Silva I (1990) Chronic intrathecal baclofen administration in severe spasticity. Stereotact Funct Neurosurg 54–55: 147–53.
Lazorthes Y, Sallerin-Caute B, Verdie J C, Bastide R, Carillo J P (1990) Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 72: 393–402.
Loubser P G, Narayan R K, Sandin K J, Donovan W H, Russel K D (1991) Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia 29(1): 48–64.
Sahuquillo J, Muxi T, Noguer M, Jodar R, Closa C, Rubio E et al (1991) Intraspinal baclofen in the treatment of severe spasticity and spasms. Acta Neurochir (Wien) 110: 166–173.
Meythaler J M, Steers W D, Tuel S M, Cross L L, Haworth C S (1992) Continuous intrathecal baclofen in spinal cord spasticity. Am J Phys Med Rehabil 71: 321–7.
Stevens C W, Yaksh T L (1989) Potency of infused spinal anti-nociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J Pharmacol Exp Ther 250(1): 321–7.
Price G W, Wilkin G P, Turnbull M J, Bowery N G (1984) Are baclofen-sensitive GABA-B receptors present on primary afferent terminals of the spinal cord? Nature 307: 71–4.
Golstein A, Aronow L, Kalman S M, editors (1974) Principles of Drug Action. John Wiley & Sons, New York: 459–68.
Penn R D, Kroin J S (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1: 1078.
Author information
Authors and Affiliations
Additional information
This study will be presented as a poster in IRMA-VII Washington DC, April 9–16, 1994.
Rights and permissions
About this article
Cite this article
Akman, M., Loubser, P., Donovan, W. et al. Intrathecal baclofen: does tolerance occur?. Spinal Cord 31, 516–520 (1993). https://doi.org/10.1038/sc.1993.84
Issue Date:
DOI: https://doi.org/10.1038/sc.1993.84
Keywords
This article is cited by
-
Évaluation des pratiques professionnelles : l’implantation de pompes à baclofène a fait l’objet d’une évaluation
La Lettre de médecine physique et de réadaptation (2007)